GSA CAPITAL PARTNERS LLP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$201
-65.6%
7,287
-55.6%
0.02%
-76.7%
Q4 2022$585
-99.8%
16,394
+63.6%
0.07%
+69.8%
Q1 2022$324,000
-68.2%
10,023
-76.6%
0.04%
-63.9%
Q4 2019$1,018,000
+274.3%
42,925
+334.2%
0.12%
+221.6%
Q3 2019$272,000
-5.9%
9,886
+13.6%
0.04%
+12.1%
Q4 2018$289,000
-86.5%
8,700
-75.7%
0.03%
-68.9%
Q2 2018$2,141,000
-24.8%
35,777
-42.4%
0.11%
-29.8%
Q1 2018$2,846,000
+6.4%
62,134
-7.4%
0.15%
-7.4%
Q4 2017$2,675,000
+62.6%
67,134
+63.2%
0.16%
+45.5%
Q3 2017$1,645,000
-64.9%
41,134
-62.2%
0.11%
-63.4%
Q2 2017$4,686,000
+8.6%
108,734
-21.1%
0.31%
+31.9%
Q1 2017$4,314,000
+34.7%
137,834
+8.7%
0.23%
+21.5%
Q4 2016$3,202,000
+2.2%
126,829
+0.1%
0.19%
+13.7%
Q3 2016$3,134,000
-26.9%
126,734
-39.8%
0.17%
-29.1%
Q2 2016$4,286,000
+11.5%
210,429
-16.5%
0.24%
-3.3%
Q1 2016$3,845,000
+30.3%
252,109
+14.8%
0.24%
+70.1%
Q4 2015$2,951,000
-1.9%
219,572
+2.4%
0.14%
-2.7%
Q3 2015$3,008,000
+48.3%
214,379
+79.5%
0.15%
+89.7%
Q2 2015$2,028,000119,4060.08%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders